Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors
Ce dossier présente un ensemble d'articles analysant les facteurs associés au risque de nausées et vomissements induits par la chimiothérapie, et évaluant la prévention et la prise en charge de ces effets indésirables chez les patients atteints de cancer
Chemotherapy-induced nausea and vomiting (CINV) is common among cancer patients. Early identification of patients at risk for CINV may help to personalize anti-emetic therapies. To date, few studies have examined the combined contributions of patient-reported and genetic risk factors to CINV. The goal of this study was to evaluate these risk factors.